The study, published in the Journal of Agriculture and Food Research, examined six Shanxia long black pigs with an average live weight of 105 kilograms, reared under identical conditions at a breeding company in Jiangxi province. From each animal, the researchers harvested four depots: abdominal backfat and thoracic backfat, both from the subcutaneous layer; visceral fat from the greater omentum, the apron-like tissue draped over the intestines; and leaf fat, the perirenal depot surrounding the kidneys. Each depot yielded six biological replicates, frozen within thirty minutes of slaughter to preserve the molecular state of the tissue.

To profile the lipids, the team ground each frozen sample under liquid nitrogen and extracted lipids with a methyl tert-butyl ether and methanol mixture spiked with internal standards. The extracts were then separated on a C30 ultra-performance liquid chromatography column and analyzed on a triple quadrupole mass spectrometer operating in multiple reaction monitoring mode, a targeted technique that allows precise quantification of hundreds of individual lipid molecules by tracking their characteristic fragmentation transitions. In total, the researchers identified 668 lipid species spanning five major categories and thirty-four subcategories, including 317 triglycerides, more than a hundred ceramides, and dozens of phosphatidylcholines, phosphatidylethanolamines and related membrane lipids.

The most striking finding concerns what dominates each depot. Triglycerides, the classic storage lipids, made up between roughly 81 and 91 percent of the lipid content in all four tissues, but free fatty acids were significantly more abundant in the two visceral depots—the greater omentum fat and the leaf fat—than in the two subcutaneous depots. When the researchers applied principal component analysis and orthogonal partial least-squares discriminant analysis to the full lipid dataset, all four tissues separated clearly, with the strongest divergence between thoracic backfat and visceral fat and the mildest between thoracic backfat and leaf fat. The statistical models showed high explanatory power and predictive ability, with permutation testing over 200 iterations confirming that the separations were not artifacts of overfitting.

Perhaps most practically, the team identified signature lipids that can distinguish the depots from one another. Ceramides of the alpha-hydroxy fatty acid-sphingosine class, combined with phosphatidylcholine, reliably separate thoracic backfat, omental fat and leaf fat, while triglycerides distinguish abdominal backfat from leaf fat. In the comparison between thoracic backfat and leaf fat, nine of the ten lipid markers with the greatest statistical weight were ceramides, all far more abundant in the backfat. Ceramides are not passive structural molecules; they are bioactive signaling lipids implicated in obesity, insulin resistance, type 2 diabetes and even thermogenesis regulation, which means their differential distribution across pig depots may matter both for lard quality and for understanding metabolic disease.

The transcriptomic arm of the study reinforced and extended the lipid picture. The researchers sequenced strand-specific libraries from the same tissues, generating more than 182 gigabase pairs of clean data aligned to the pig reference genome, with an average mapping rate of nearly 96.5 percent. Quantitative PCR validation of eight selected genes confirmed the reliability of the sequencing. The numbers of differentially expressed genes between depots ranged from 555 to 2,433, and a consistent hierarchy emerged: omental visceral fat showed the most transcriptionally active profile, with up to 79 percent of differentially expressed genes upregulated in comparisons against other depots, while leaf fat was transcriptionally the quietest. Enrichment analysis showed that visceral fat was dominated by immune and signaling pathways—cytokine-cytokine receptor interactions, leukocyte-mediated immunity, chemokine signaling—whereas comparisons between the two subcutaneous depots highlighted metabolic pathways, fatty acid metabolism and the PPAR signaling pathway.

The researchers then took the analysis a step further by integrating the two data types, a strategy they describe as transcriptomic-lipidomic association analysis. Because only certain pathways were enriched in both datasets, they focused on two comparisons: thoracic backfat versus leaf fat, and omental fat versus leaf fat. In the first, Pearson correlation analysis within the shared metabolic pathways revealed 103 lipids and 22 genes with strong, statistically significant correlations, defined as a correlation coefficient exceeding 0.8 in absolute value. Six genes stood out as hubs connected to more than ten lipid species each: ENPP6, PLD4, CA13, HDC, CBR2 and SCD.

The biology behind these correlations is suggestive. ENPP6 encodes a choline-specific phosphodiesterase that breaks down lysophosphatidylcholine, and its concurrent elevation with ceramide abundance raises the possibility that phospholipid catabolism feeds intermediates into ceramide biosynthesis or reshapes membrane microdomains that govern ceramide signaling. CA13, a carbonic anhydrase, may support de novo fat synthesis by supplying bicarbonate for pyruvate carboxylase. HDC, the rate-limiting enzyme of histamine production, is known from mouse studies to influence energy balance—mice lacking the gene develop visceral obesity and impaired glucose tolerance. Most intriguingly, SCD, the stearoyl-CoA desaturase that converts saturated fatty acids into monounsaturated ones, showed negative correlations with most ceramide species, hinting that subcutaneous fat actively keeps its ceramide pool unsaturated to preserve membrane fluidity, while visceral fat, with lower SCD expression, may accumulate more saturated ceramides and thus greater metabolic risk. In the visceral comparison, the growth factor gene FGF7 correlated most strongly with phosphatidylcholine and lysophosphatidylcholine species, suggesting a possible role in driving the conversion of lysophosphatidylcholine into phosphatidylcholine through the lipid remodeling pathway known as the Lands cycle.

The authors are careful to note the limits of their study. With six animals per depot, the statistical power is adequate for profiling but limited for detecting subtle effects, and no gene knockdown or overexpression experiments were performed, so the gene-lipid associations remain correlative rather than causal. They propose future functional work—such as CRISPR-mediated suppression of ENPP6 or SCD in pig adipocytes followed by targeted lipidomics—to test whether these genes genuinely control depot lipid composition. They also suggest that the lipid markers identified here could eventually serve in market supervision and authenticity testing, distinguishing the anatomical origin of fat products, though larger sample sets would be needed to validate such applications.

The broader implications run in two directions. For the swine industry, the results offer a molecular basis for the differentiated use of pig fat, a resource of considerable economic and culinary importance in China, where lard remains a traditional cooking oil. Knowing that subcutaneous depots specialize in triglyceride storage while visceral depots concentrate signaling lipids could guide breeding programs seeking to reduce unwanted fat deposition without sacrificing the intramuscular fat that underpins tenderness, juiciness and flavor. For human health, the parallels are direct: human adipose biology shows the same subcutaneous-versus-visceral dichotomy, with visceral fat strongly linked to insulin resistance and cardiometabolic disease. A molecular atlas of how these depots diverge in a large animal model—one far closer to human physiology than rodents—may help researchers pinpoint which lipid species and regulatory genes drive those differences, and how they might be therapeutically targeted. In showing that a pig’s fat is really four chemically distinct organs wearing the same name, the study turns a humble by-product into a rich system for exploring one of metabolism’s oldest questions: why fat stored in different places behaves so differently.

The groundbreaking research culminated in a comprehensive adipose tissue atlas, capturing detailed gene expression data linked to cellular functions in both healthy and unhealthy obese individuals. Researchers like Adhideb Ghosh, associated with ETH Zurich, focus their efforts on uncovering the biological markers that distinguish healthy obese individuals from those who develop metabolic diseases. By identifying the cellular variations in adipose tissues, this study aims to facilitate new strategies for the diagnosis and treatment of metabolic disorders.

Utilizing the Leipzig Obesity Biobank, which houses an extensive collection of adipose tissue samples from individuals who underwent elective surgery, the authors of the study meticulously compared the genetic activities within samples sourced from both healthy and unhealthy obese participants. This biobank offers paired health data alongside adipose tissue samples, allowing for a precise analysis of the cellular landscape within adipose tissues specific to metabolic health status. In examining samples from 70 volunteers, researchers notably focused on two distinct types of adipose tissue, namely subcutaneous and visceral fat, which differ significantly in their functional roles and health implications.

Visceral adipose tissue is widely recognized for its association with greater risks of metabolic diseases due to its deep-seated location in the abdominal cavity, enveloping vital organs. In contrast, subcutaneous fat, located directly beneath the skin, is generally considered less dangerous. A critical point of interest in this study lies in characterizing the cellular compositions and interactions in these tissue types, particularly considering that adipose tissue is not merely a mass of fat cells, or adipocytes. It also contains various other cell types, including immune cells and precursor cells, which collectively influence the tissue’s overall functionality.

Discerning the intricacies of adipose tissue cellular dynamics proved vital for the researchers. They delineated that in individuals suffering from metabolic diseases, gene activity indicated substantial functional alterations among virtually all cellular constituents of visceral fat. Specifically, adipocytes from unhealthy individuals demonstrated an impaired capacity for fat oxidation while simultaneously increasing their production of immunologic signaling molecules. This elevation in immune responses within visceral fat is hypothesized to contribute to the onset and progression of metabolic diseases among this population.

Moreover, the study unearthed intriguing distinctions in the presence and function of mesothelial cells—cells that form the outer boundary of visceral adipose tissues. Remarkably, a significantly higher proportion of these cells was observed in healthy obese individuals, paired with enhanced functional versatility. These mesothelial cells possess the ability to adapt into a stem cell-like state, leading to the differentiation into various other cell types, including adipocytes. Such plasticity in these boundary cells is a phenomenon traditionally associated with cancer; thereby, its occurrence in healthy adipose tissue was a surprising yet promising revelation.

Gender differences also emerged as a prominent theme in the research, as specific progenitor cells were identified exclusively in the visceral adipose tissue of women. This finding raises questions about the biological underpinnings that contribute to differentiating metabolic health between genders, providing a foundation for further explorations in understanding how genetics and biology influence disease predisposition.

The implications of this new atlas of gene activity extend far beyond mere academic curiosity. It serves as a critical resource for researchers aiming to pinpoint biomarkers that could indicate an individual’s risk for developing metabolic diseases. The dataset enables the identification and characterization of cellular alterations that could herald the onset of these disorders, paving the way for timely interventions and personalized medical approaches.

Furthermore, the adaptability of the research is underscored by the authors’ commitment to making their findings accessible to the wider scientific community. By publishing the data in a publicly available web application, they encourage collaborative efforts amongst researchers to further investigate the identified patterns and their ramifications for metabolic health. This openness marks a significant step towards fostering a culture of transparency and shared knowledge in medical research, particularly in complex fields like obesity and metabolism.

As the search for effective biomarkers continues, the researchers are actively exploring potential avenues for clinical applications arising from their findings. An example includes the burgeoning class of medications designed to suppress appetite while enhancing insulin release in the pancreas, albeit facing limitations in availability. The identification of robust biomarkers could inform healthcare providers on who may benefit most from these treatments, thereby optimizing patient outcomes.

In summary, the revelations from this study underscore the necessity of delving deeper into the biological complexity underlying obesity and metabolic health. Such explorations not only enhance our understanding of the human body but also serve a critical role in shaping future therapeutic strategies and public health initiatives aimed at effectively addressing the global obesity epidemic and associated metabolic diseases. The delineation between healthy and unhealthy obesity creates a pathway for new research inquiries and medical innovations, shaping the future of nutrition, health care, and personalized medicine.

Subject of Research: Obesity and Metabolic Health
Article Title: Unveiling adipose populations linked to metabolic health in obesity
News Publication Date: 17-Dec-2024
Web References: 10.1016/j.cmet.2024.11.006
References: Reinisch I, Ghosh A, Noé F, et al. Unveiling adipose populations linked to metabolic health in obesity. Cell Metabolism, 2025, 37: 1.
Image Credits: Not provided
Keywords: Obesity, Metabolic Health, Adipose Tissue, Biomarkers, Gender Differences, Gene Activity, Visceral Fat, Subcutaneous Fat, Metabolic Diseases, Insulin Release, Immune Response, Public Health